MVK and PFAPA syndrome: Gattorno et al. have demonstrated that 83% of patients with mevalonate kinase deficiency, 57% of patients with TRAPS, and 8% of patients with FMF have met the criteria for PFAPA syndrome (Gattorno et al., 2009).